The indications for combined treatment with trifluoperazine and amylobarbitone.
D000654:Amobarbital / Q000628:therapy*; D009497:Neurotic Disorders / Q000628:therapy*; D011612:Psychosurgery; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000628:therapy*; D014149:Tranquilizing Agents / Q000628:therapy*; D014268:Trifluoperazine
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D000654:Amobarbital
AMOBARBITAL/therapy; NEUROSES/therapy; PSYCHOSES/therapy; TRANQUILIZING AGENTS/therapy